Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression

• Hauptverfasser: Noriaki Arakawa (Verfasst von), Shinichiro Matsuyama (Verfasst von), Masaru Matsuoka (Verfasst von), Isao Kitamura (Verfasst von), Keiko Miyashita (Verfasst von), Yutaro Kitagawa (Verfasst von), Kazuo Imai (Verfasst von), Kumiko Ogawa (Verfasst von), Takuya Maeda (Verfasst von), Yoshiro Saito (Verfasst von), Chihiro Hasegawa (Verfasst von)
• Format: Buch
• Veröffentlicht: Elsevier, 2022-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

The prognosis of patients with severe cases of COVID-19 is poor; thus, biomarkers for earlier prediction of COVID-19 progression are vital. We measured levels of five lung injury-related biomarkers, SP-D, KL-6, presepsin, kallistatin and stratifin, in serum samples collected serially during hospital...